Why Clearside Biomedical Stock Surged Today
Shares of Clearside Biomedical (NASDAQ: CLSD) jumped on Thursday following bullish analyst commentary. As of 3 p.m. EDT, the biopharmaceutical company's stock price was up more than 12% after rising as much as 47% earlier in the day.
Clearside Biomedical is developing an experimental treatment for wet age-related macular degeneration (AMD). The biotech announced positive phase 1/2a safety results on Tuesday for CLS-AX, which showed that the drug was well tolerated with no serious adverse events reported during the trial.
Investors bid up eye care specialist Clearside Biomedical's shares on Thursday. Image source: Getty Images.
Source Fool.com
